![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 31, 2013 8:43:45 PM
Most recently they were a prime player in the development and marketing of the blockbuster drug, Lexapro, among others.
What especially interests me and it's commercial value is staggering if the drug comes to market, is a drug in phase III testing that extends the 3- hour window for a heart attack patient to get to the hospital for treatment to avoid catastrophic damage, to a 9 hour window. Yes NINE hours.
This, if the tests continue as they have to date, will revolutionize the treatment of cardiac event victims.
HLUYY can be bought like any stock, no special commissions, etc., and, imo, one's portfolio of truly established and continually promising drug companies, should include HLUYY.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM